Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will report first quarter 2024 financial results
GlobeNewswireApr 23 16:05 ET
Express News | Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
Moomoo 24/7Apr 22 16:05 ET
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Stock Price Dropped 15% Last Week; Individual Investors Would Not Be Happy
Key Insights The considerable ownership by individual investors in Clover Health Investments indicates that they collectively have a greater say in management and business strategy 40% of the busine
Simply Wall StApr 17 08:14 ET
Fitch Flags Medicare Utilization Trends Ahead of Managed Care Earnings
Seeking AlphaApr 10 13:58 ET
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6,600 IU/mL (6.4-fold increase) and approximately 46,000 IU/mL (12-fold increase), respectively -- --
PR NewswireApr 8 05:12 ET
On April 2, Clover Health Investments Corp Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
On April 2, Clover Health Investments Corp Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
BenzingaApr 5 16:10 ET
Clover Health Provides Notice Associated With Previously Disclosed Settlement of Shareholder Derivative Actions
FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on Form 10-Q for the
GlobeNewswireApr 4 16:30 ET
Managed Care Stocks Drop After Medicare Rate Decision
Seeking AlphaApr 2 10:44 ET
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
BenzingaMar 26 08:54 ET
Medicare Expands Coverage for Weight Loss Drugs
Seeking AlphaMar 21 13:35 ET
Cautious Optimism on Clover Health's Performance With Concerns on Long-Term Profitability
TipRanksMar 21 02:18 ET
Clover Health Launches New Clinical Program In Partnership With Quartet Health To Address Serious Mental Illness
Clover Health ("Clover" or the "Company") announced a partnership with Quartet Health, a value-based behavioral health care enablement and delivery company, to increase the support and resources provi
BenzingaMar 19 09:00 ET
Clover Health Launches New Clinical Program in Partnership With Quartet Health to Address Serious Mental Illness
Yahoo FinanceMar 19 09:00 ET
Clover Health(CLOV.US) Director Buys US$109.96K in Common Stocks
$Clover Health(CLOV.US)$ Director Loengard Anna U purchased 150.63K shares of Common Stocks on Mar 14, 2024 at an average price of $0.73 for a total value of $109.96K.Source: Announcement What is stat
moomoo NewsMar 18 17:14 ET
Downgrade: Here's How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near Term
The latest analyst coverage could presage a bad day for Clover Health Investments, Corp. (NASDAQ:CLOV), with the analysts making across-the-board cuts to their statutory estimates that might leave sha
Simply Wall StMar 18 07:11 ET
Peering Into Clover Health Investments's Recent Short Interest
Clover Health Investments's (NYSE:CLOV) short percent of float has risen 6.6% since its last report. The company recently reported that it has 29.52 million shares sold short, which is 7.43% of all re
BenzingaMar 15 12:15 ET
Clover Health Investments Full Year 2023 Earnings: Beats Expectations
Yahoo FinanceMar 14 07:40 ET
Q4 2023 Clover Health Investments Corp Earnings Call
Yahoo FinanceMar 13 07:52 ET
Clover Health Investments: A Strong Buy on Rising Revenues, Improved Cost Management, and a Path to Profitability
TipRanksMar 13 07:07 ET
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday. Shares of The Beauty Health Company (NASDAQ:SKIN) rose sharply in today's pre-market tra
BenzingaMar 13 06:16 ET
No Data
No Data